AbbVie has collaborated with UK-based drug discovery firm Mission Therapeutics for research and preclinical development of potential therapies to treat Alzheimer’s disease and Parkinson’s disease. The partners will focus on compounds that selectively target deubiquitylating […]
PCI has unveiled plans for an expansion of its clinical site at Rockford, IL. Construction of the expanded clinical services facility began on November 12, 2018. The site is one of two U.S.-based PCI locations supporting […]
AstraZeneca’s Imfinzi (durvalumab) monotherapy and the combination of Imfinzi with remelimumab have failed to improve overall survival (OS) rate in phase III Mystic lung cancer trial. The company has reported the final OS results for […]
Boehringer Ingelheim has entered into a new global collaboration with Epizyme to develop novel epigenetic oncology therapies. As part of the collaboration worth $300m, Boehringer and Epizyme will involve in the research, development and commercialization […]
Swiss multinational, Lonza Pharma & Biotech has opened its Collaborative Innovation Centre (CIC) in Israel to help accelerate new therapies and manufacturing practices. Based in the Haifa Life Science Park, the facility includes lab space […]